- Latest news▼
-
15:32, April 26 ESCMID: New method of purifying the air with ultraviolet light could protect world from new pandemic
-
08:43, April 26 Enzymes that convert different blood groups into first group are discovered
-
19:41, April 25 Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference
-
17:31, April 25 JAMA: patient grew long, curly eyelashes because of chemotherapy
-
11:08, April 25 Mpox epidemic declared in Republic of the Congo
-
08:31, April 25 OU: quitting smoking 4 times more likely to cure laryngeal cancer
-
01:20, April 25 Paralyzed man in China writes hieroglyphs using neural implants placed in his brain
-
15:11, April 24 Zombie deer disease possibly linked to hunters’ deaths
-
12:27, April 23 Appetite: Scientists found out the secret to the appeal of large portions of fast food
-
10:33, April 23 Scientists test new approach to fighting viruses
-
08:38, April 23 Ketamine may help with postpartum depression
-
22:12, April 22 Unhealthy amount of sugar found in baby food products of a well-known brand
-
19:41, April 22 Air pollution puts health of more than 1.6 billion workers globally at risk
-
17:25, April 22 Scientists found baked goods and lack of sleep to be more dangerous than alcohol
-
16:02, April 22 342 cases of measles recorded in Armenia so far in 2024
All materials
ETVAX vaccine against E. coli diarrhea proves to be effective
November 22, 2019 09:43
Scientists from the University of Gothenburg completed the trial of ETVAX vaccine, the first vaccine in the world against enterotoxigenic E. coli diarrhea.
The vaccine which consists of inactivated E. coli bacteria expressing protective antigens and the ETEC-based B subunit protein LCTBA was tested among children from 6 months to 5 years of age.
Enterotoxigenic E. coli is the main reason for the development of diarrhea in children and tourists, Vax Before Travel reported.
Based on the results of this trial, advanced studies were initiated in September 2019 to further test safety, immune responses and protection of ETVAX (including dmLT) in African children 6-23 months of age.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference
- First Armenian-German Conference entitled “Heart Failure Spring School”
- Allogeneic bone marrow transplant in case of hematological malignancy performed in Armenia for first time
All materials
- Archive
- Most read
month
week
day
- Scientists found baked goods and lack of sleep to be more dangerous than alcohol 1072
- Unhealthy amount of sugar found in baby food products of a well-known brand 1014
- Air pollution puts health of more than 1.6 billion workers globally at risk 1007
- Ketamine may help with postpartum depression 991
- 342 cases of measles recorded in Armenia so far in 2024 990
- Appetite: Scientists found out the secret to the appeal of large portions of fast food 989
- Scientists test new approach to fighting viruses 969
- Zombie deer disease possibly linked to hunters’ deaths 949
- Cognitively stimulating jobs in midlife could lower dementia risk in old age, study finds 851
- BrainStimulation: electrical brain stimulation alleviates anxiety and depression in the elderly 780
- Mpox epidemic declared in Republic of the Congo 733
- Paralyzed man in China writes hieroglyphs using neural implants placed in his brain 728
- JAMA: patient grew long, curly eyelashes because of chemotherapy 654
- Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference 640
- OU: quitting smoking 4 times more likely to cure laryngeal cancer 630
- Find us on Facebook
- Poll
Are you aware that in 2027 medical insurance will become mandatory for all Armenian citizens?